During the last session, Niagen Bioscience Inc (NASDAQ:NAGE)’s traded shares were 0.68 million, with the beta value of the company hitting 2.19. At the end of the trading day, the stock’s price was $6.77, reflecting an intraday loss of -8.39% or -$0.62. The 52-week high for the NAGE share is $9.18, that puts it down -35.6 from that peak though still a striking 65.88% gain since the share price plummeted to a 52-week low of $2.31. The company’s market capitalization is $526.37M, and the average intraday trading volume over the past 10 days was 0.57 million shares, and the average trade volume was 808.18K shares over the past three months.
Niagen Bioscience Inc (NASDAQ:NAGE) trade information
Niagen Bioscience Inc (NAGE) registered a -8.39% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -8.39% in intraday trading to $6.77, hitting a weekly high. The stock’s 5-day price performance is -12.65%, and it has moved by 24.45% in 30 days. Based on these gigs, the overall price performance for the year is 76.30%. The short interest in Niagen Bioscience Inc (NASDAQ:NAGE) is 2.11 million shares and it means that shorts have 5.91 day(s) to cover.
Niagen Bioscience Inc (NAGE) estimates and forecasts
In the rating firms’ projections, revenue will increase 18.98% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 27.07M as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 28.3M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 22.15M and 22.74M respectively. In this case, analysts expect current quarter sales to grow by 22.22% and then jump by 24.46% in the coming quarter.
While earnings are projected to return 18.18% in 2025, the next five years will return 28.79% per annum.
NAGE Dividends
Niagen Bioscience Inc is due to release its next quarterly earnings on 2025-Mar-03. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Niagen Bioscience Inc (NASDAQ:NAGE)’s Major holders
Niagen Bioscience Inc insiders own 34.79% of total outstanding shares while institutional holders control 30.00%, with the float percentage being 46.01%.
Also, the Mutual Funds coming in first place with the largest holdings of Niagen Bioscience Inc (NAGE) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 2.12 shares. This amounts to just over 2.73 percent of the company’s overall shares, with a $14.38 million market value. The same data shows that the other fund manager holds slightly less at 1.31, or about 1.69% of the stock, which is worth about $8.87 million.
